Alzheimer's Archives - The Florida Capital Star

Author Spotlight: Cleo Childs

July 31, 2024 Bethany Bowman

Not too far removed from singers/songwriters are poets. Songs are just poetry set to music. Author Cleo Childs debuted her first spoken word project in May. The work entitled Moving With is a collection of 14 poems set to music. It was written throughout her personal, emotional journey as she witnessed her mother’s brave struggle through the stages of Alzheimer’s.

Childs’ mother passed in 2021 from early onset Alzheimer’s when she was just 28 and it sent her into a deep depression. She tried to “intellectually” get over it by learning everything she could about grief.

Florida to Spend $65 Million for Alzheimer’s, Dementia Care

July 21, 2023July 20, 2023 The Center Square

Florida Lt. Gov. Jeanette Nuñez says the $65 million appropriated by the Legislature will help Alzheimer’s and dementia patients with technology and resources.

Florida is home to more than 4.4 million people 65 and older, making up over 20% of the population. Because of this, Nuñez said at a news conference in Ocala on Wednesday that it has been a priority of leadership to make sure Floridians have the opportunity to live long, secure lives, and funding for Alzheimer’s and dementia will help achieve that.

Music Spotlight: Jay Allen

May 14, 2023 Bethany Bowman

When rising artist Jay Allen debuted the song “No Prayer Like Mama’s,” I knew this was the artist I wanted to feature for Mother’s Day Weekend. To be honest, the lyrics just wreck me, and I suppose that is what a good country song does.

Allen grew up in a little Midwest town in Iowa where his dad owned a restaurant called Joe’s Country Grill. That’s where his dad met his mother when she was a waitress. Because they both worked at the restaurant, Allen spent much of his younger years there.

FDA Approves New Drug for Early Treatment of Alzheimer’s

January 8, 2023January 7, 2023 Just the News

The U.S. Food and Drug Administration on Friday approved a new drug to treat Alzheimer’s disease, with testing reportedly showing considerable success in helping patients with the debilitating condition.

The FDA said in a press release that it had approved the drug Leqembi for Alzheimer’s patients. The drug is “the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiology of the disease,” the agency said.

Commentary: Expanding Access to Alzheimer’s Treatment

September 4, 2022September 3, 2022 RealClearWire

Promising new medicines could soon be available to help patients fend against this disease. Government must ensure Medicare is able to cover them.

Approximately six million Americans are living with some form of Alzheimer’s, a number poised to double over the coming decades. Citizens are living 30 years longer than a century ago, primarily due to incredible advances in the field of medicine. Future opportunities are limitless if we foster an environment that rewards rather than discourages innovation. Unfortunately, that’s not what our leaders in Washington are doing.

Buddy Carter Commentary: Democrats’ Heads Are in the Clouds When It Comes to Lowering Drug Prices

July 11, 2022July 10, 2022 Admin

Republicans have a plan to combat high prescription drug prices, without reverting to socialist price controls.

When I was a practicing pharmacist, I witnessed seniors trying to decide whether to pay for their medicine or pay for their groceries. I witnessed mothers crying because they couldn’t afford their children’s medicine.

Commentary: Alzheimer’s Research Pipeline Is Poised to Conquer Alzheimer’s with Combination Drug Treatments

November 20, 2021November 19, 2021 RealClearWire

The recent approval of Aduhelm, a drug that removes amyloid plaques from the brains of people with Alzheimer’s, is a reason for cautious celebration. Not just because it is the first new treatment approved in 17 years, but because it is the first piece of a complex puzzle that researchers are hot on the trail of solving.